Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy
出版年份 2022 全文链接
标题
Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 24, Pages 15554
出版商
MDPI AG
发表日期
2022-12-09
DOI
10.3390/ijms232415554
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden
- (2022) Julia Femel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment
- (2022) Simone Kloch Bendtsen et al. OncoImmunology
- Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer
- (2022) Brie Chun et al. Journal for ImmunoTherapy of Cancer
- Galectin-9 supports primary T cell transendothelial migration in a glycan and integrin dependent manner
- (2022) Adel Abo Mansour et al. BIOMEDICINE & PHARMACOTHERAPY
- Hypoxia controls the glycome signature and galectin-8 – ligand axis to promote pro-tumorigenic properties of metastatic melanoma.
- (2022) Asmi Chakraborty et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Galectin-9 as a biomarker of disease severity
- (2021) Preeti Moar et al. CELLULAR IMMUNOLOGY
- Genetic glycoengineering in mammalian cells
- (2021) Yoshiki Narimatsu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
- (2021) Riyao Yang et al. Nature Communications
- An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016–present)
- (2021) Aaftaab Sethi et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Crosstalk between WNT and STAT3 is mediated by galectin-3 in tumor progression
- (2021) Seok-Jun Kim et al. Gastric Cancer
- Selective 13 C‐Labels on Repeating Glycan Oligomers to Reveal Protein Binding Epitopes through NMR: Polylactosamine Binding to Galectins
- (2021) María J. Moure et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A minigene DNA vaccine encoding peptide epitopes derived from Galectin-1 has protective antitumoral effects in a model of neuroblastoma
- (2021) Laura Liebscher et al. CANCER LETTERS
- Selectively Deoxyfluorinated N ‐Acetyllactosamine Analogues as 19 F NMR Probes to Study Carbohydrate‐Galectin Interactions
- (2021) Martin Kurfiřt et al. CHEMISTRY-A EUROPEAN JOURNAL
- Immunoprotective neo-glycoproteins: Chemoenzymatic synthesis of multivalent glycomimetics for inhibition of cancer-related galectin-3
- (2021) Viktoria Heine et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting galectins in T cell-based immunotherapy within tumor microenvironment
- (2021) Qiu-Yang Jin et al. LIFE SCIENCES
- Galectin‐9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin‐dependent manner
- (2021) Asif J. Iqbal et al. FASEB JOURNAL
- Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
- (2021) Guillermo A. Videla-Richardson et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia
- (2020) Xin He et al. BLOOD
- β4GALT1 controls β1 integrin function to govern thrombopoiesis and hematopoietic stem cell homeostasis
- (2020) Silvia Giannini et al. Nature Communications
- Computational Prediction and Validation of Tumor-Associated Neoantigens
- (2020) Vladimir Roudko et al. Frontiers in Immunology
- Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival
- (2020) Yu-Li Su et al. Cells
- Impact of Galectins in Resistance to Anticancer Therapies
- (2020) Pilar Navarro et al. CLINICAL CANCER RESEARCH
- Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy
- (2020) Simone Nüssing et al. Frontiers in Immunology
- Structures and mechanism of human glycosyltransferase β1,3-N-acetylglucosaminyltransferase 2 (B3GNT2), an important player in immune homeostasis
- (2020) Yue Hao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-9 bridges human B cells to vascular endothelium while programming regulatory pathways
- (2020) Asmi Chakraborty et al. JOURNAL OF AUTOIMMUNITY
- Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma
- (2019) Qun Chen et al. INTERNATIONAL JOURNAL OF CANCER
- The First Step in Adoptive Cell Immunotherapeutics: Assuring Cell Delivery via Glycoengineering
- (2019) Robert Sackstein Frontiers in Immunology
- Decoding the sweet regulation of apoptosis: the role of glycosylation and galectins in apoptotic signaling pathways
- (2019) Kamil Seyrek et al. CELL DEATH AND DIFFERENTIATION
- Glycoengineering of chimeric antigen receptor (CAR) T-cells to enforce E-selectin binding
- (2019) Nandini Mondal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-1–driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance
- (2019) Dhanya K. Nambiar et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment
- (2019) Li Yang et al. Journal of Hematology & Oncology
- Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression
- (2019) María Romina Girotti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sialic acid blockade suppresses tumor growth by enhancing T cell-mediated tumor immunity
- (2018) Christian Büll et al. CANCER RESEARCH
- Glycan-directed CAR-T cells
- (2018) Catharina Steentoft et al. GLYCOBIOLOGY
- Poly-N-Acetyllactosamine Neo-Glycoproteins as Nanomolar Ligands of Human Galectin-3: Binding Kinetics and Modeling
- (2018) Ladislav Bumba et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Galectins in Tumors and in Clinical Immunotherapy
- (2018) Feng-Cheng Chou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives
- (2018) Kamil Wdowiak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CD206-positive myeloid cells bind galectin-9 and promote a tumor-supportive microenvironment
- (2018) Elizabeth Ann L Enninga et al. JOURNAL OF PATHOLOGY
- Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk
- (2018) Carlos A. Orozco et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic control of T cell immune response through glycans in inflammatory bowel disease
- (2018) Ana M. Dias et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Untangling Galectin-Driven Regulatory Circuits in Autoimmune Inflammation
- (2018) Marta A. Toscano et al. TRENDS IN MOLECULAR MEDICINE
- The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment
- (2018) Mohammad Farhad et al. OncoImmunology
- Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma
- (2018) Xinqi Wu et al. OncoImmunology
- Loss of GCNT2/I-branched glycans enhances melanoma growth and survival
- (2018) Jenna Geddes Sweeney et al. Nature Communications
- Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans
- (2018) N. Giovannone et al. Nature Communications
- The role of galectin-3 in heart failure and cardiovascular disease
- (2018) Xiao Zhong et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin–glycan specificities in a natural context
- (2018) Mathias Ingemann Nielsen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human B Cell Differentiation Is Characterized by Progressive Remodeling of O-Linked Glycans
- (2018) Nicholas Giovannone et al. Frontiers in Immunology
- Glycans as Key Checkpoints of T Cell Activity and Function
- (2018) Márcia S. Pereira et al. Frontiers in Immunology
- A Single-Step Chemoenzymatic Reaction for the Construction of Antibody–Cell Conjugates
- (2018) Jie Li et al. ACS Central Science
- Galectin-9 binds to O-glycans on protein disulfide isomerase
- (2017) Katrin Schaefer et al. GLYCOBIOLOGY
- Galectin-1: A Jack-of-All-Trades in the Resolution of Acute and Chronic Inflammation
- (2017) Victoria Sundblad et al. JOURNAL OF IMMUNOLOGY
- Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
- (2017) Donnele Daley et al. NATURE MEDICINE
- Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration
- (2017) Monica Gordon-Alonso et al. Nature Communications
- Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
- (2017) Martin Lauss et al. Nature Communications
- The N-terminal tail coordinates with carbohydrate recognition domain to mediate galectin-3 induced apoptosis in T cells
- (2017) Huiting Xue et al. Oncotarget
- Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes
- (2017) Xinqi Wu et al. Cancer Immunology Research
- Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment
- (2017) Irene Scarfò et al. Journal for ImmunoTherapy of Cancer
- Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanisms
- (2016) J. M. Lykken et al. BLOOD
- Galectins: their network and roles in immunity/tumor growth control
- (2016) Herbert Kaltner et al. HISTOCHEMISTRY AND CELL BIOLOGY
- A key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies
- (2016) Judy R. van Beijnum et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Basis for Recognition of the Cancer Glycobiomarker, LacdiNAc (GalNAc[β1→4]GlcNAc), byWisteria floribundaAgglutinin
- (2016) Omid Haji-Ghassemi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-9: From cell biology to complex disease dynamics
- (2016) Sebastian John et al. JOURNAL OF BIOSCIENCES
- Glycoengineering of E-Selectin Ligands by Intracellular versus Extracellular Fucosylation Differentially Affects Osteotropism of Human Mesenchymal Stem Cells
- (2016) Brad Dykstra et al. STEM CELLS
- Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
- (2016) P-F Zhang et al. Cell Death & Disease
- O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer
- (2016) Sofia N. Santos et al. Oncotarget
- Using CRISPR-Cas9 to quantify the contributions of O-glycans, N-glycans and Glycosphingolipids to human leukocyte-endothelium adhesion
- (2016) Gino Stolfa et al. Scientific Reports
- Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo
- (2015) KOJI FUJITA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Galectin-1 Regulates Tissue Exit of Specific Dendritic Cell Populations
- (2015) Sandra Thiemann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer immunotherapy: harnessing the immune system to battle cancer
- (2015) Yiping Yang JOURNAL OF CLINICAL INVESTIGATION
- Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant Potential
- (2015) Erika M. Yazawa et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Engineered CHO cells for production of diverse, homogeneous glycoproteins
- (2015) Zhang Yang et al. NATURE BIOTECHNOLOGY
- CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells
- (2015) Alexander J. Davenport et al. Cancer Immunology Research
- Galectin 1 Proangiogenic and Promigratory Effects in the Hs683 Oligodendroglioma Model Are Partly Mediated through the Control of BEX2 Expression
- (2015) Marie Le Mercier et al. NEOPLASIA
- Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T Cells
- (2014) Chuan Wu et al. IMMUNITY
- Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions
- (2014) K. Nagahara et al. JOURNAL OF IMMUNOLOGY
- Acquired and intrinsic resistance in cancer immunotherapy
- (2014) Sander Kelderman et al. Molecular Oncology
- Tumour heterogeneity and the evolution of polyclonal drug resistance
- (2014) Rebecca A. Burrell et al. Molecular Oncology
- Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection
- (2014) P. R. Kumaresan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Galectin-9 in tumor biology: A jack of multiple trades
- (2013) Roy Heusschen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Unraveling galectin-1 as a novel therapeutic target for cancer
- (2013) Lucile Astorgues-Xerri et al. CANCER TREATMENT REVIEWS
- Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity
- (2013) Tina Verschuere et al. INTERNATIONAL JOURNAL OF CANCER
- Galectin-3 Accelerates the Progression of Oral Tongue Squamous Cell Carcinoma via a Wnt/β-catenin-Dependent Pathway
- (2013) Li-Ping Wang et al. PATHOLOGY & ONCOLOGY RESEARCH
- Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
- (2013) L.-C. S. Wang et al. Cancer Immunology Research
- Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death
- (2012) M. C. Clark et al. BLOOD
- Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease
- (2012) T. Dalotto-Moreno et al. CANCER RESEARCH
- Inhibiting galectin-1 reduces murine lung metastasis with increased CD4+ and CD8+ T cells and reduced cancer cell adherence
- (2012) Koichi Ito et al. CLINICAL & EXPERIMENTAL METASTASIS
- Overexpression of galectin-3 enhances migration of colon cancer cells related to activation of the K-Ras–Raf–Erk1/2 pathway
- (2012) Keng-Liang Wu et al. JOURNAL OF GASTROENTEROLOGY
- Galectin-1 Triggers an Immunoregulatory Signature in Th Cells Functionally Defined by IL-10 Expression
- (2012) F. Cedeno-Laurent et al. JOURNAL OF IMMUNOLOGY
- Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome
- (2012) Cory D Rillahan et al. Nature Chemical Biology
- Glycoengineering of HCELL, the Human Bone Marrow Homing Receptor: Sweetly Programming Cell Migration
- (2011) Robert Sackstein ANNALS OF BIOMEDICAL ENGINEERING
- Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha
- (2011) Els M. E. Verdegaal et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Galectin-1 research in T cell immunity: Past, present and future
- (2011) Filiberto Cedeno-Laurent et al. CLINICAL IMMUNOLOGY
- Peracetylated 4-Fluoro-glucosamine Reduces the Content and Repertoire ofN- andO-Glycans without Direct Incorporation
- (2011) Steven R. Barthel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolic Inhibition of Galectin-1-Binding Carbohydrates Accentuates Antitumor Immunity
- (2011) Filiberto Cedeno-Laurent et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice
- (2010) N. Demotte et al. CANCER RESEARCH
- Galectin multimerization and lattice formation are regulated by linker region structure
- (2010) L. A. Earl et al. GLYCOBIOLOGY
- Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
- (2010) Anna I. Markowska et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tim-3/Galectin-9 Pathway: Regulation of Th1 Immunity through Promotion of CD11b+Ly-6G+ Myeloid Cells
- (2010) V. Dardalhon et al. JOURNAL OF IMMUNOLOGY
- Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death
- (2010) B Brandt et al. Cell Death & Disease
- Role of apoptosis resistance in immune evasion and metastasis of colorectal cancer
- (2010) Kebin Liu World Journal of Gastrointestinal Oncology
- Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration
- (2009) Robert Sackstein IMMUNOLOGICAL REVIEWS
- Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10
- (2009) Juan M Ilarregui et al. NATURE IMMUNOLOGY
- Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices
- (2008) A. Nobumoto et al. GLYCOBIOLOGY
- Structural Features of Galectin-9 and Galectin-1 That Determine Distinct T Cell Death Pathways
- (2008) Shuguang Bi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines
- (2008) Tae-Young Jung et al. JOURNAL OF NEUROSURGERY
- Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone
- (2008) Robert Sackstein et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now